SINGAPORE, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Novotech , the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at ...
COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. ...
September 7, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic ...
LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received ...
August 30, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issue of EUR 500 million fixed rate notes due 2031 (the “Notes”) ...
Completed enrollment in 12-week Phase 2a study of oral GLP-1 receptor agonist, GSBR-1290 Topline data from Phase 2a and Phase 1b multiple ascending dose study of GSBR-1290 expected in latter half of fourth quarter 2023 SAN FRANCISCO, ...
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Conagen , the bioplatform innovator and biomanufacturer, and Sumitomo Chemical , Japan's leading chemical company, have announced to jointly develop p -hydroxystyrene (HS) and its polymer, ...
July 24, 2023 Second-quarter highlights Group sales increased to EUR 4.5 billion, with 9% comparable sales growth Income from operations amounted to EUR 221 million, compared to EUR 11 million in Q2 2022 Adjusted EBITA increased ...
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a ...
MoonLake Immunotherapeutics Announces Pricin g of $ 40 0 Million Upsized Public Offering of Class A Ordinary Shares ZUG, Switzerland, June 28, 2023 – MoonLake Immunotherapeutics (Nasdaq:MLTX) (“MoonLake”), a ...
Work-related diseases and injuries were responsible for the deaths of 1.9 million people in 2016 , according to the first joint estimates from the World Health Organisation (WHO) and International Labour Organisation (ILO). These ...
COVID-19 has displaced labor in mass and made people face the challenge of moving between jobs to find new work. Problems in the transitions might occur when workers fail to move smoothly to a new position using their existing skills. ...
AI and big data/analytics are identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes, according to a survey by GlobalData, a leading data and analytics ...
During the COVID-19 lockdown, insurance companies like Oscar Health were worried if people had adequate food and how they planned to stay stocked up during the lockdown. ...
Various unparalleled events happening since last few months have upended societies and healthcare systems alike. Monetary and drug donations have become the main tactics employed by drug developers, but there is now pressure to decline royalties linked to the development of COVID-19 fighting drugs, according to GlobalData, a leading data and analytics company....
Subscribe to our Free Newsletters!